Ramin Garmany (@GarmanyRamin) header
Ramin Garmany (@GarmanyRamin) profile picture

IM PGY1 @MayoClinic | MD @MayoClinicSOM, PhD @MayoGradSchool | Interested in genetic cardiology, epigenetics, omics, and molecular pharmacology | Views my own

Joined May 2020
Photo by Ramin Garmany (@GarmanyRamin)Photo by Ramin Garmany (@GarmanyRamin)Photo by Ramin Garmany (@GarmanyRamin)Photo by Ramin Garmany (@GarmanyRamin)Photo by Ramin Garmany (@GarmanyRamin)
Quite the #AHA2026 hat trick! 🎯 Grateful for the opportunity to share some of our work today. Big thanks to my mentors @JohnGiudicessi @MJAckermanMDPhD and to the whole team. @MayoClinicWSRGH @MCastrichiniMD @GarmanyRamin Now we keep pushing! #ScientificSessions26
Last day of #AHA2026, but @GiovanniMultinu is going strong with not 1 but 3 presentations covering the role of transmural LGE, LV hypertrabeculation and myocarditis episodes in genotype-positive ACM/DCM in the same cardiomyopathy session. @MayoClinicCV @MayoClinicWSRGH
1
1
17
534
Grateful to present our study from @MayoClinicCV at #ESCCongress in Munich showing an increased AI ECG Age Gap Predicts Risk of Heart Failure Events in Patients with PKP2-cardiomyopathy! @JohnGiudicessi @MJAckermanMDPhD @MCastrichiniMD – at Munich, Germany
2
1
9
1,982
More work from the Mayo Genetic Cardiomyopathy/ACM team! Doesn’t matter the cardiomyopathy, having >1 P/LP variant is associated with worse outcomes. Congrats to Dr. Nouraee @MayoMN_IMRES and thanks to @hrs_journal @MayoClinicCV @MayoClinicWSRGH.
3
11
2,486
Not all transmural LGE on cardiac MRI is ischemic. 5% of ACM/DCM patients, primarily those with P/LP variants in LMNA and DSP, have transmural LGE and represent a high-risk subset. @JACCJournals @MayoClinicCV @MCastrichiniMD @GarmanyRamin @GiovanniMultinu jacc.org/doi/10.1016/j.jacep…
8
16
2,082
So proud of 3 MD/PhD students from @MayoClinicSOM & @MayoGradSchool who graduated yesterday. Sahej and her PhD work on #gene #therapy for #LQTS & Ramin and his work on #HCM over these past 6+ years has been so appreciated. And Jake (far left) is married to one of my scientists 🤗
1
3
38
2,194
Strong work @MCastrichiniMD and big thanks to the nearly 1,500 genotype-positive ACM/DCM patients/families in our @MayoClinicCV @MayoClinicWSRGH Genetic Cardiomyopathy registry who made this and exciting ongoing work possible!
PKP2-ACM patients display a distinct recovery phase arrhythmic profile predictive of MVA events, emphasizing the importance of EST in risk stratification and management. Future studies are needed jacc.org/doi/10.1016/j.jacep… #JACCCEP #EPeeps #Cardiomyopathy @JohnGiudicessi
1
4
19
3,966
🔥 Thrilled to share our most recent study on the outcomes of VT ablation for LMNA Cardiomyopathy 🫀⚡️ 📌 Despite ablation, rates of recurrent VT and death were remarkably elevated. 🙏🏽 Huge thanks to the team @MCastrichiniMD @VizentinVanessa @JohnGiudicessi @MJAckermanMDPhD
3
3
22
1,640
Big shootout to Dr. Reid Schlesinger an ⁦@MayoMN_IMRES⁩ resident for his work on the potential role of variant type in ventricular arrhythmias in RBM20-related cardiomyopathy that was published simultaneously in ⁦@JACCJournals⁩ during ⁦AHA! jacc.org/doi/10.1016/j.jacep…
1
11
2,137
🚨PKP2-ACM patients show a distinct recovery-phase arrhythmic profile on EST—predictive of major ventricular arrhythmias. Read more 👉jacc.org/doi/10.1016/j.jacep… @MayoCVFellows @MayoClinicCV #CardioTwitter #EPeeps
Arrhythmias in recovery are usually not a good sign. This example here is in PKP2. Others have shown in other diseases. Is PKP2 distinct from DSP or is it an issue of sample size and selection jacc.org/doi/10.1016/j.jacep… #cardiotwitter
1
3
10
1,761
PKP2-ACM is associated with a distinct ventricular arrhythmia pattern on exercise stress test that may carry prognostic significance. Strong work in @JACCJournals from @MayoClinicCV fellow @MCastrichiniMD and the @MayoClinicWSRGH team! authors.elsevier.com/a/1ljK1…
3
5
21
1,479
Ramin Garmany retweeted
In cardiac laminopathy, missense variants in the IgD domain show a unique "pseudo-infarct" pattern on MRI, with higher risk of ventricular arrhythmias and stroke. #AHAJournals @MCastrichiniMD @MJAckermanMDPhD @JohnGiudicessi @MayoClinicCV ahajrnls.org/45q1x9n
2
5
23
1,879
📣 📣 Don’t miss our oral presentation at #HeartRhythm2025 in San Diego! “Prognostic Significance of Exercise Stress Testing in Desmosomal ACM” April 25 | Hub 5 | Sails Pavilion @JohnGiudicessi @MJAckermanMDPhD @MayoEPFellows @MayoCVFellows #EPeeps #HRS2025 Let’s talk rhythm!🫀🎶
4
26
1,866
Ramin Garmany retweeted
RBM20 cardiomyopathy carries a more significant burden at a younger age, and an accelerated course compared to TTN cardiomyopathy pmc.ncbi.nlm.nih.gov/article… #CardioTwitter
5
17
1,415
Glad to see our @JAMANetworkOpen study out. The study brings attention to the growing healthspan-lifespan gap across the world and reveals the largest gap in the US. The study documents a larger healthspan-lifespan gap in women associated with a disease burden disparity.
The global healthspan-lifespan gap has widened to 9.6 years over the past two decades, with women experiencing a larger gap than men, and is associated with increased noncommunicable diseases and overall morbidity, particularly in the US. ja.ma/4inyvwV
4
3
18
1,472
From Dan Ye + @MJAckermanMDPhD: Clinical Utility of Protein Language Models in Resolution of VUSs in KCNQ1, KCNH2, and SCN5A Compared to Patch Clamp Functional Characterization ahajournals.org/doi/abs/10.1… @AHAScience #AHAjournals #CardioTwitter #Genetics 🎥@hj_tadros
6
1
18
1,610
Happy to see our manuscript characterizing sex-specific differences in the multi-omics profile of HCM officially published! Grateful to @MJAckermanMDPhD and my co-authors for making this possible. sciencedirect.com/science/ar…
2
2
15
1,421
Congrats @ArminGarmany!
.@MayoClinic research is investigating the health effects of space travel on private citizens. A @MayoProceedings @ArminGarmany paper shares findings of the health response of the first all-civilian astronaut mission to the International Space Station. mayocl.in/3MEkZWJ
10
499